The coronavirus (COVID-19) situation is evolving, and advice is being regularly updated by the Australian Government and state and territory health departments.
On this page we have evidence-based information for healthcare professionals and for consumers.
Report and discuss possible side effects following a COVID-19 vaccination by calling our Adverse Medicine Events (AME) Line on 1300 134 237. Monday–Sunday 8am–8pm AEDT/AEST (excluding public holidays).
Click here for resources in multiple languages.
Managing COVID-19: information and latest evidence for health professionals
COVID-19 vaccine support
09 May 2022
COVID-19 vaccine booster doses
13 Dec 2021
COVID-19 vaccination in children and adolescents
13 Dec 2021
Influenza vaccines and COVID-19
Quality prescribing
24 Feb 2022
Antiviral treatments for COVID-19
24 Feb 2022
Oral antivirals and sotrovimab
26 Oct 2021
Information for prescribers
27 Oct 2021
Information for pharmacists
Podcast
In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks with Prof Sarah Hilmer and Prof Josh Davis, members of the National COVID-19 Clinical Evidence Taskforce Guidelines Leadership Group. They give an update on the new antiviral treatments now available and answer some frequently asked COVID management questions.
Being medicinewise during COVID-19: information for consumers
General COVID-19 information
-
Australian Government coronavirus essential information
-
healthdirect COVID-19 information
-
healthdirect Get COVID Clarity
-
healthdirect What happens after you recover from COVID-19?
-
healthdirect information about rapid antigen tests
-
Choosing Wisely Australia COVID-19 information
-
World Health Organization myth busters
Community members share why they got vaccinated
The Department of Health website features videos from five community members who explain why they chose to get vaccinated. The translated videos are in English, Arabic, Hindi, Indonesian, Samoan and Urdu.
Australian Prescriber COVID-19-related articles and podcasts
28 Feb 2022
Molnupiravir for COVID-19
28 Feb 2022
Casirivimab and imdevimab for COVID-19
28 Feb 2022
Nirmatrelvir and ritonavir for COVID-19
01 Oct 2021
Sotrovimab for COVID-19
National COVID-19 Clinical Evidence Taskforce recommendations
NPS MedicineWise is a partner to the work of the National COVID-19 Clinical Evidence Taskforce (the Taskforce) which is producing ‘living’ guidelines to support front-line clinicians with reliable and up-to-date advice on the latest evidence.
Members of the Taskforce include peak health professional bodies whose members are providing clinical care to people with COVID-19, and the guidelines are specific to managing COVID-19 across mild, moderate, severe and critical illness.
For the latest guidance please visit the Taskforce website https://covid19evidence.net.au/#living-guidelines
NPS MedicineWise is supporting the work of the Taskforce by helping clinicians to understand how to implement relevant guidelines into clinical practice. This includes publication of evidence summaries on medicines and tests, and working through Choosing Wisely Australia to support implementation into healthcare protocols and systems.